Saba Capital Management, L.P.'s Form 4 filing
BlackRock Health Sciences Term Trust (BMEZ) · filed Nov 17, 2023
- Accession no.
- 0001510281-23-000510
- Filed
- Nov 17, 2023, 5:01 PM ET
- Trade date
- Nov 15-17, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $4.30M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saba Capital Management, L.P.CIK 0001510281 | 10% Owner |
| Weinstein BoazCIK 0001608233 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Common Stock | PPurchaseAcquired | +135,047 | $13.63 | +$1,840,690.61 | 13,141,422 | Indirect | |
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +85,481 | $13.62 | +$1,164,251.22 | 13,226,903 | Indirect | |
| Nov 17, 2023 | Common Stock | PPurchaseAcquired | +95,390 | $13.59 | +$1,296,350.1 | 13,322,293 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.